BioCatalystWatch
TVTXWorkspace / TVTX / OverviewCompany library
Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc.

Travere Therapeutics, Inc. (TVTX)

Website

Price
Market cap
Next catalystExpected 2H 2027pegtibatinase (TVT-058) — classical homocystinuria · Phase 3 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

pegtibatinase (TVT-058)

Upcoming / outlook

sparsentan (FILSPARI)

Endothelin A receptor (ETA) × Angiotensin II type 1 receptor (AT1)

Upcoming / outlook

sparsentan (FILSPARI)

Endothelin A receptor (ETA) × Angiotensin II type 1 receptor (AT1)

Upcoming / outlook

sparsentan (FILSPARI)

Endothelin A receptor (ETA) × Angiotensin II type 1 receptor (AT1)

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

sparsentan (FILSPARI)

Endothelin A receptor (ETA) × Angiotensin II type 1 receptor (AT1)

Upcoming / outlook

sparsentan (FILSPARI)

Endothelin A receptor (ETA) × Angiotensin II type 1 receptor (AT1)

Upcoming / outlook

sparsentan (FILSPARI)

Endothelin A receptor (ETA) × Angiotensin II type 1 receptor (AT1)

Upcoming / outlook

pegtibatinase (TVT-058)

Upcoming / outlook

Other pipelines

civorebrutinib

BTK

PreINDP1P2P3FilingApproved

Approved / commercial

sparsentan (FILSPARI)

Endothelin A receptor (ETA) × Angiotensin II type 1 receptor (AT1)

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TVTX PR & News

TVTX SEC archive